Vitality Watch

Dossier pubmed preclinical 23-sep-2026
Animal model, organoid, or cell-culture result — not yet human

A probioticconverts hesperidin to bioactive hesperetin and improves metabolic dysfunction in aging mice.

Key claim: A probiotic strain (CL256B) that converts hesperidin to hesperetin improved metabolic health, body composition, hepatic steatosis, and grip strength in aging mice on a Western diet by activating the CISD2 longevity pathway.

Abstract

Dietary flavonoids often require microbial metabolism to generate bioactive metabolites that influence host physiology. Hesperidin, a citrus flavanone glycoside, exhibits limited intestinal absorption and depends on gut microbial biotransformation to yield its active aglycone, hesperetin. Hesperetin activates CDGSH iron-sulfur domain 2 (CISD2), a pro-longevity gene whose expression declines with age, and its pharmacological activation has emerged as a strategy to promote healthy aging. Here, we identified a probiotic strain,CL256B, that efficiently converts hesperidin to hesperetin via coordinated-L-rhamnosidase and-glucosidase activities, achieving ~90% bioconversion efficiency. In naturally aging mice challenged with a Western diet, six-month treatment with probiotic-derived hesperetin significantly improved age-associated metabolic phenotypes, including reduced body weight and adiposity, increased lean mass, enhanced muscle integrity and grip strength, and attenuation of hepatic steatosis. In addition, glucose tolerance, insulin sensitivity, and whole-body energy metabolism were improved. Transcriptomic analyses revealed activation of SIRT1 and HNF4α signaling in the liver and restoration of ribosome homeostasis in skeletal muscle. These findings support a microbiome-enabled strategy in which probiotic-assisted hesperetin bioconversion activates the CISD2 longevity pathway to improve metabolic health during aging.

Why this matters

The CL256B finding illustrates a distinct twist in the probiotic-for-aging narrative: the strain is valued not for colonizing the gut but for enzymatically converting a dietary flavonoid (hesperidin, abundant in citrus) into its more bioactive aglycone (hesperetin), which then engages the CISD2 longevity pathway. That framing — probiotic-as-bioconverter of food polyphenols — is likely to be picked up by supplement marketers pairing citrus extracts with specific strains, well ahead of any human trial. The evidence remains a single aged-mouse Western-diet study [animal-model].

Source

Link

Briefing card

A probioticconverts hesperidin to bioactive hesperetin and improves metabolic dysfunction in aging mice.
Stage: preclinical · pubmed · 23-sep-2026

If you take hesperidin supplements expecting metabolic benefits, this mouse study suggests the effect depends on whether your gut microbes convert it to hesperetin — a step that varies between individuals and has not been tested in humans.

A probiotic strain (CL256B) that converts hesperidin to hesperetin improved metabolic health, body composition, hepatic steatosis, and grip strength in aging mice on a Western diet by activating the CISD2 longevity pathway.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1080/19490976.2026.2736902

build build 880 · 2bcef25 · 2026-11-18